intro china chc & thc market reports 2013

1Loudon Far EastLoudon Far East

Multi-client reports prepared for the healthcare industry

By

Date: June 2013

Introduction to “2013 China Broad Market Reports”CHC & THC Markets Landscape Studies


Contents

Report Objectives & Methodology

Sampling Plan

Illustrative Outputs

Contents of Report

Cost of Reports


Key Questions to Identify China CHC & THC Market OpportunitiesThese questions are answered in the reports

• Size of CHC/THC segments, potential, growth & which provinces to target?

• Patients profile: healthcare coverage, objectives of the visits?

• What diseases are diagnosed in CHCs & THCs?

• What diseases are treated in CHCs & THCs? (e.g.: HRT?, BPH?, HBV?, etc)

• Hospital specialties & physicians’ unmet needs, what can MNCs do?

• Patients unmet needs & what can MNCs do?

• Prescription switching & brand loyalty ?

• Patients consulting processes: diagnosis, initiation, retention, leverage points for MNCs?

• Patients perception of imported/JV products by TAs & premium they are willing to pay?

• Is e-marketing the right approach in China to target CHCs & THCs?

1

2

3

4

5

6

7

8

9

10


What’s New in 2013 Reports?Compared to 2010 reports “China CHC Market Landscape Studies”

• Add a brand new report about China THC Market

• Update the CHC & THC market facts based upon the latest data and information

• Incorporate the latest policies regarding CHCs & THCs ( i.e.: Listing, tendering, etc.)

• Increase the sample size of physicians and patients interviews:

– from 2,700 to 6,000 patients FTF Interviews

– from 270 to 290 physicians FTF Interviews

• Integrated “e-marketing opportunities report” into both CHC & THC individual reports

• Lower subscription fees vs 2010:

– China CHC & THC Market Overview – Supply & Demand Sides 100,000 RMB incl. additional valuable information on THC market but same subscription as in 2010.

– China CHC Market Opportunities – Physicians & Patients Perspectives TBD Integrate information on both Physicians AND Patients (2010 value 300,000 RMB)

and e-marketing opportunities report information (2010 value: 70,000 RMB)

– China THC Market Opportunities – Physicians & Patients Perspectives TBDNew report available (not available in 2010), integrate information on e-marketing opportunities


Wide Range of Data Sources & Resources

Loudon’s Data Collection Loudon Databases

Hospital Database• MOH hospital databases • CHC database • THC databases• PLA hospital database

City Database• Demography • Social Economics• Healthcare expenditure• Healthcare data base

Primary and secondary marketing research

Desk Research• Loudon database • Public information in provincial MOH and other

domains

Qualitative In-Depth Interviews (IDIs)• 12 IDIs with CHC physicians• 12 IDIs with CHC patients • 12 IDIs with THC physicians• 12 IDIs with THC patients

Quantitative Face to Face Interviews (FTFs)• 3,000 FTFs with CHC patients • 3,000 FTFs with THC patients• 290 FTFs with physicians


• Patients caseload & Diseases type

• Key drivers to go to CHC and THC

• Satisfaction of CHC, THC services and unmet needs

• Staff profile and specialties set up in CHC, THC

• Numbers of medicines (WM, TCMs) in pharmacies

• Typical CHC, THC physicians prescription behaviors

• Physician information channel and unmet needs

• Number of CHC and hospitals, physicians, hospital beds by provinces

• CHC, THC out patients caseload by provinces

• Population, aged population, GDP income status , Healthcare expenditures by provinces

• CHC, THC out patient visit average expenditure by provinces

• Segment of CHC and THC market by size, key parameters of suppliers and demanders.

• Finalize research and analysis plans

• Review of internal data and reports

• Develop analysis plan

Phase:

Module:

Deliverable: • Survey plans

• Guidelines

• Question-naires

Physician interviews • 12 In-depth interviews with CHC physicians• 12 In-depth interviews with THC physicians• 290 face to face interviews with physicians

a

Preparation Phase I: Market Landscape Phase II: Market Opportunities

The Landscape Study are Divided Into Two PhasesPublic information, Loudon databases, interviews of physicians and patients

Patient interviews • 12 In-depth interviews with CHC patients• 12 In-depth interviews with CHC patients• 6,000 face to face interviews with patients

Desk Survey•Loudon database •Public information in provincial MOH and other domains

a

Data Base• MOH hospital databases • CHC database • THC databases• PLA hospital database

b b


Contents


Sampling Plan


Contents of Report

Cost of Reports


Data Collection Plan Physician and Patient Interviews (1/2)290 IDIs with physicians and 6,000 FTFs with patients

THC

Tier I

Tier II

Physician

Numbers of Interviews

Beijing

Wuhan

15

8

5

8

8

CHC

Shanghai

Guangzhou

Shenyang

15

15

8

8

15

Physician

8Chengdu 8

8Xi’an

300

300

160

160

300

Patients

160

Patients

300

160

100

160

160

160

160

Nanjing

8

8

160

160 5 100

Tier III

Foshan 6

6Taizhou

6

6

6Baoding 6

6Taiyuan

120

120

120

120

120

120

1206 120


Tier IV

Tier V

Data Collection Plan Physician and Patient Interviews (2/2)290 IDIs with physicians and 6,000 FTFs with patients

Kunshan

Xianyang

6

6

6

5

6

Fushun

Huizhou

Suining

4

4

4

3

4

5Jingmen 3

5Yuyao

80

80

80

75

80

75

120

120

120

110

120

110

110

Dandong

3

3

75

75 5 110

Tier VI

Jieshou 3

3Penglai

2

2

3Honghu 2

3DJY

50

50

50

75

75

75

752 50

145Total 3,000145 3,000

THC

Physician

Numbers of Interviews

CHC

Physician Patients Patients


Study Was Conducted In 24 Cities & 9 ProvincesWestern Medicine Expenditure ranking from No. 1 to No. 626

Source: Loudon in house database

ShanghaiWuhan

Chengdu Tier I cityUrban pop: 13.5 Mn .Urban disposable income/cap: RMB 23.6 K

Tier II cityUrban pop.: 6.9 .Urban disposable

Tier I cityUrban pop: 8.3 Mn .

Beijing

Tier I city.

Urban disposable

Shenyang

Guangzhou

Nanjing

Tier II cityUrban pop.: 7.4 Mn .Urban disposable

Suining

Tier II cityUrban pop: 14.1 Mn .Urban disposable

Tier II cityUrban pop: 11.2 Mn .Urban disposable income/cap: RMB 16.9 K

Tier II cityUrban pop: 7.4 Mn .Urban disposable income/cap: RMB 13.9 K

Tier VITier VTier I Tier II Tier III Tier IV

Taiyuan

Taizhou

Baoding

KunsanXi’an

Xianyang

Jingmen

Yuyao

JieshouDJY

Foshan

Fushun

Huizhou

Dandong

Penglai

Honghu

Tier I city

Pop(Mil.) Ranking

WME

Shanghai 2.30 1

Beijing 1.96 2

Guangzhou 1.27 3

Tier II city

Pop(Mil.) Ranking

WME

Wuhan 0.98 6

Nanjing 0.81 7

Chengdu 1.40 9

Shenyang 0.81 11

Xi'an 0.85 19

Tier III city

Pop(Mil.) Ranking

WME

Foshan 0.72 29

Tiayuan 0.42 34

Taizhou 0.46 38

Baoding 1.12 50

Tier IV city

Pop(Mil.) Ranking

WME

Huizhou 0.46 62

Kunsan 0.16 106

Xianyang 0.51 112

Fushun 0.21 158

Tier V city

Pop(Mil.) Ranking

WME

Yuyao 0.10 182

Suining 0.33 184

Jingmen 0.29 203

Dandong 0.24 204

Tier VI city

Pop(Mil.) Ranking

WME

Penglai 0.045 356

DJY 0.066 460

Jieshou 0.056 538

Honghu 0.082 626


Contents


Sampling Plan


Contents of Report

Cost of Reports


25.0

2.0

33.816.0

46.2

25.0

15.5

9.0

23.0

13.0

9.033.8 24.0

46.230.0

15.5

7.017.0

8.0

3.0

33.0 24.0

46.036.0

16.0

11.0

18.0

Pharma Market & Hospital Segments in ShanxiCHC only accounts for 2.0% of total Shanxi pharma market

Shanxi Hospital Segments

Illustrative

Source: Loudon Analysis, MOPH & CHC Database, Dummy slides

PLA Hospitals (S3) (N=5)

IMS Hospital Audit

RMB (Bn.)

MS

MOH Hos

<100 Beds

(S2) (N=720)

Community

Health Center

(Station)

(S4) (N=530)

S1S3S2 S4

MOH Hos ≥100 beds

(S1) (N=300)

TOT

Size (beds)

Patient Caseload by Segments

WME by Segments

Shanxi Pharma Market Segments

Hospital Beds Number by Segments

>=800

500-799

300-499

<300

CHC (Station)

THC

Size (beds)

>=800

500-799

300-499

<300

CHC (Station)

THC

Size (beds)

>=800

500-799

300-499

<300

CHC (Station)

THC

2.50 0.51 0.10 0.07 0.20 3.38

74.0% 15.1% 3.0% 2.1% 5.9% 100.0%

1.0

2.0

2.0

16.0

46.0

33.0

(% of hospitals) (% of beds)

(% of hospitals) (% of patient caseload)

(% of hospital) (% of WME)

1.0

2.0

2.0

16.0

46.0

33.0

1.0

2.0

2.0

16.0

46.0

33.0

Township

Health Center

(S5) (N=1500)

S5


Top 400 CHCs Account for 50% of CHC MarketMarket concentration is in line with primary care chronicle disease market

0%

20%

40%

60%

80%

100%

0 20 40 60 80 100 120 140 160 180 200 220 240 260

Hyperlipidemia

HRT

A rare disease

Oncology

HBP

CHC Market Compared with 5 TA Markets

% of WME

Rank by Hospital Potential

Market Share of Top 50 hospitals Top Hospitals to Cover 50% Market

HBP 15.1% 349 hospitals

Hyperlipidemia 14.5% 330 hospitals

HRT 33.0% 112 hospitals

Oncology 52.8% 43 hospitals

A rare disease 72.3% 20 hospitals

CHC 19.6% 400 CHCs

0%

20%

40%

60%

80%

100%

0 20 40 60 80 100 120 140 160 180 200 220 240 260

HBP

% of WME

Rank by Hospital Potential

MOH Hos <100 Beds

MOH Hos ≥100 beds

CHC Market Compared with MOH Hos Markets

CHC CHC

HRT

Illustrative


CHC WME Potential Is Deviated Very Much Geographically

Normal Distribution Graph of CHC Market Size

Prioritized Market 1

Total CHC Market




Normal Distribution Graph of CHC Market SizeOptimize Your Sales Force Resource

0

4

8

12

16

0

10

20

30

40

50

60

Group I II III IV V Others

Number of sales call#

of sa

les ca

lls

Maximize ROI of sales from high potential CHCs

Sales, product prescriptions

Optimize the sales call to most potential CHCs

WM

E (

Mn

. R

MB

)

1.080.700.680.57 0.85 WME (Mn. RMB)

Illustrative


Shanghai

WuhanChengdu

Beijing

Shenyang

Nanjing

Hangzhou

Tianjin

Chongqing

Ningbo

Shenzhen

Changsha

Jinan

Harbing

Zhengzhou

Fuzhou

Qingdao

Wenzhou

Xi’An

Kunming

Changchun

Guangzhou

Suzhou

Total # of CHCs

WME (Bn. RMB)

Top 23 cities

% of Total CHC market

75.0%7,500 6.30

Shanghai

WuhanChengdu

Beijing

Shenyang

Nanjing

Hangzhou

Tianjin

Chongqing

Ningbo

Shenzhen

Changsha

Jinan

Harbing

Zhengzhou

Fuzhou

Qingdao

Wenzhou

Xi’An

Kunming

Changchun

Guangzhou

Suzhou

Total # of CHCs

WME (Bn. RMB)

Top 23 cities

Top 23 cities + 50 KM


75.0%

85.0%

7,500

14,900

6.30

7.00

Shanghai

WuhanChengdu

Beijing

Shenyang

Nanjing

Hangzhou

Tianjin

Chongqing

Ningbo

Shenzhen

Changsha

Jinan

Harbing

Zhengzhou

Fuzhou

Qingdao

Wenzhou

Xi’An

Kunming

Changchun

Guangzhou

Suzhou

Total # of CHCs

WME (Bn. RMB)

Top 23 cities

Top 23 cities + 50 KM

Top 23 cities + 2hr fast train


75.0%

85.0%

88.0%

7,500

14,900

16,900

6.30

7.00

7.50

Sources: Loudon analysis

China CHC Territory Management Strategy Scenario III: Focus on Top 23 CitiesCHC potential Analysis on its 2hrs economic circle

Illustrative


CHC Departments and Patient Size

Department% of

CHCs

# of half day

practice per week

Weekly Patient Size in OPD

MonthlyPatient Size in

IPD

IM/General practice大内科 / 全科 100.0 11.3 423.4 0.0

Precaution and health care预防保健科 87.2 8.7 125.0 0.0

TCM (TCM&WM )中医科（中西医结合科） 83.0 9.8 207.9 0.0

Gynecology (Obstetrics) 妇科（产科） 78.1 9.9 155.0 0.0

Surgery 外科 76.6 10.3 230.6 19.5

Dentistry 牙科 72.1 9.9 73.0 0.0

Acupuncture & massage针灸推拿科 69.1 9.3 26.5 0.0

Physical therapy理疗科 66.4 9.4 80.0 0.0

Pediatric 儿科 63.0 9.7 180.0 0.0

ENT 耳鼻喉科 53.2 8.8 113.0 0.0

Child care儿童保健科 40.8 9.2 102.0 0.0

WM 西医科 1.5 10.3 347.5 0.0

Orthopedics 骨科 1.1 10.0 163.3 15.0

Dermatology 皮肤科 0.8 10.0 135.0 0.0

Pain management疼痛科 0.4 10.0 250.0 20.0

ER 急诊科 0.4 14.0 118.3 0.0

Average Number of Departments Per CHC

In-patient Department Setting in CHC

CHCs Have an average of 8 Depts and 48% of CHCs Have In-Patient Dept.All CHCs have set up IM/general practice

47.536.7

44.4

62.4

Total Tier I Tier II Tier III

% of CHC with IPD

47.5% 36.7% 44.4% 62.4%

# of beds per CHC

51.8 81.2 56.3 30.1

7.9 8.9 8.1 6.8

Source: Loudon analysis, Physician FTF interview SA, A1,A2, A4

More than 50% of hospitals have these Top 10 depts

Total Tier I Tier II Tier III

# of physicians/ CHC

31 40 35 17

# of physicians/ dept.CHC

3.9 4.5 4.3 2.5

Illustrative


Convenient Location is the Main Reason for Patients to Go to CHCs

Key Drivers for Visiting CHCs (% of patients)

Close to home

Medicines are cheaper than level II or III hospitals

Little illness, no necessary to visit big hospitals

Fewer patients, less time for queuing

Free registration fee

CHC physicians is nice and patient

Familiar with CHC physicians

Consult firstly, see if the disease is serious

Can ask for appointed drugs

Vaccination, no necessary to visit big hospitals

The service quality CHC been improved

Injection, no necessary to visit big hospitals

Take examination, no needs to visit big hospitals

Not strict, you can use the family member's card

Not strict, you can use several cards to avoid medical insurance cap

8.7

7.2

5.7

5.2

4.3

84.7

31.1

30.0

24.9

18.4

17.3

13.5

11.0

1.5

1.3

Tier I Cities Tier II Cities Tie III Cities

87.2 84.1 82.7

35.7 37.9 19.7

23.7 36.3 29.9

30.2 29.7 14.7

15.9 23.3 15.9

12.7 23.0 16.3

15.3 11.4 13.8

8.2 14.0 10.8

18.4 4.6 3.0

8.2 7.9 5.4

5.0 6.3 5.9

1.9 8.3 5.2

3.6 5.2 4.1

2.2 1.6 0.7

2.7 0.8 0.3

Illustrative


Diagnosis % of Patients

Disease 1 60.0

Disease 2 10.0

Disease 3 5.0

Disease 4 4.8

Disease 5 3.8

Disease 6 3.6

Disease 7 3.2

Disease 8 3.0

Disease 9 1.1

50% of Patients Come for Diagnosis75% patients are suffering from Disease 1, 2 and 3.

Source: Loudon analysis, patient FTF interview Q6, B1


Disease 10 1.0

Disease 11 0.9

Disease 12 0.7

Disease 13 0.7

Disease 14 0.6

Disease 15 0.6

Disease 16 0.5

Disease 17 0.4

Disease 18 0.4

Come for injection

4.0%

Bandage wound

3.0%

Total Patient

100%

Get vaccination in

POV

15.0%

Follow-up visit to

fill prescription

20.0%

Physician

examination

1.0%

Diagnosis

50.0%

Pregnancy and

Maternal care

2.0%

Routine exam only

5.0%

Others

10.0%

Indication or disease

Illustrative


Indication/TA % of Patients

Disease 1 30.0

Disease 2 15.0

Disease 3 9.0

Disease 4 6.0

Disease 5 3.4

Disease 6 3.4

Disease 7 3.2

Disease 8 2.1

Disease 9 1.8

20% of Patients Come to CHC for Filling Prescription Major patients have chronic disease: Disease 1,2 and 3

Source: Loudon analysis, patient FTF interview Q6, B1


Disease 10 1.8

Disease 11 1.6

Disease 12 1.3

Disease 13 1.3

Disease 14 1.3

Disease 15 1.1

Disease 16 1.1

Disease 17 1.1

Disease 18 0.8

Indication or disease

Come for injection

4.0%

Bandage wound

3.0%

Total Patient

100%

Get vaccination in

POV

15.0%

Follow-up visit to

fill prescription

20.0%

Physician

examination

1.0%

Come for

diagnosis

50.0%

Pregnancy and

Maternal care

2.0%

Routine exam only

5.0%

Others

10.0%

Illustrative


27% of Physicians Feel Dissatisfied about their Career Development Physicians required more Continuous Medical Education (CME)

Dissatisfied

Dissatisfied Neural Satisfied

Neural Satisfied


Tier I

Tier II

Tier III

• Dissatisfied organization chart of the departments

• Insufficient investment on training

• Few opportunities of academic activities and events

• Lack of expertise in specialized areas

• Too busy to learn

• Difficult to be promoted

• Help doctors to improve diagnosis experience

• Healthcare resource sharing with large hospitals

• More continuous education and academic meetings

• Software application training

• Establish more expert consultation

• Medical information services of the latest clinical development

• Attract more medical undergraduates

• More interactions of pharmaceutical companies

Satisfactions of Career Development Unmet needs

Suggestions


26.8%

22.2%

31.1%

27% of Physicians Feel Dissatisfied

27.8%

Source: Loudon analysis, Physician FTF interview B20-21

Illustrative


18.4

63.063.081.4

18.6

3.6

93.093.096.6

3.4

Local Western Medicines Occupies CHC Market A visit in CHC costs an average of 78 RMB

% of Imported and Local Medicines (% of patients)

% of Western Medicines and TCM (% of patients)

Medicine Expenditure and Medical Reimbursement

Total WM and Both WM

77.5

48.4

Total Value of Rx

Out of Pocket

Total Value of Rx

Out of Pocket

Total Value of Rx

Out of Pocket

Total Value of Rx

Out of Pocket

103.1

40.1

78.667.2

49.037.8

37.5%61.2%

14.5%22.8%

Total Patients Tier I Tier II Tier III

Both

TCM

WM

Total Local and Both Local

Both

Imported

Local

Illustrative


54.7 45.3

45% Physicians Switch Medicine when the Pre-determined are UnavailableMost physicians consider “Medicine efficacy” when switch medicine

When Pre-determined Medicine Unavailable

Medicine Switch Pattern (% of patients)

Same category different generic name

40.0%

Same generic name different brand name

35.2%

Different category 24.8%

Switch different brands among local medicines

44.7%

Switch imported to local medicine s 25.1%

Switch local to imported medicines 17.4%

Switch different brands among imported medicines

12.8%

Follow the Prescription of High Level Hospital

Not Rx and give other advices

Switch medicine

Not switch medicine

Switch medicine

63.2

60.3

45.6

32.4

29.4

22.1

19.1

10.3

4.4

Local or Imported(% of patients)

Key Consideration When Switching Drugs (% of physicians)

74.3 25.7

Medicine efficacy

Patient's disease status

Patient's economic level

Medicine side effects

Clinical experience

Reimbursement limitation

Patient's willingness

Prescription behavior

Medical rep's promotion

Illustrative


More Examinations and High Treatment Skills are Required By CHC Patients

Satisfaction Level of CHC Service (% of patients)

ExtramelyDissatisfied

10.2%

ExtramelyDissatisfied

0.6%

SomewhatSatisfied

57.5%

SomewhatDissatisfied

4.7%

Neutral27.0%

Satisfaction Level=3.7

Unmet Needs of CHC Service (% of patients)

• Some examinations is not available and lack of examination facilities in CHCs

28.9%

• CHC physicians' skill is a bit low, only to treat small diseases.

28.8%

• No OPD practice at weekend or after work 14.0%

• No emergency room 13.5%

• Not RX many medicine as medical insurance limitation

9.4%

• Appointed drugs are always unavailable 7.8%

• Bad attitude of physicians 4.4%

Illustrative


77.9

55.0

39.4

6.9

1.3

0.4

0.4

0.4

78% Physicians Think the State Investment Will Increase After “ 零差价” Policy 62% physicians in tier II cities assume more drug categories in CHC after EDL applied

Change of Drug Categories Number When EDL Applied (% of physicians)

Perceived Worries And Impact Of “ 零差价” Policy (% of physicians)

No enough subsidy and government investment will increase

More treatment will be available in CHC

CHC staff salary will decrease

CHC income/profit will decrease or have deficit

No assurance of medicine quality

Who will pay for the balance

Good for patient size increase

Personal career will be influenced

14.0

38.147.9

Will increase

Will not increase

Not sure

# of Drug Categories Tier I Cities Tier II Cities Tier III Cities

Will increase 28.9 62.2 52.9

Will not increase 14.4 12.2 15.3

Not sure 56.7 25.6 31.8

Illustrative


Contents


Sampling Plan


Contents of Report

Cost of Reports


China CHC & THC Market Overview - Supply & Demand Contents of Report (1/2)

1. Market Overview

The supply side

Market size, out patients caseload, physicians, number of community centers/hospitals including number of hospital beds by provinces. Their growth trends including patient caseload during the past years.

The demand side

Population demographics, the population is covered by three types of healthcare programs. The healthcare expenditure.

2. Market Overview - CHC/THC Supply Side

CHC pharma market: by hospital type and by province Number of CHC/THC hospitals by province Number of CHC/THC physicians by province Number of CHC/THC hospital beds by province CHCs & THCs’ outpatient caseload by province


China CHC & THC Market Overview - Supply & Demand Contents of Report (2/2)

3. Market Overview - CHC/THC Demand Side

Total CHC/THC catchment population demographic breakdown by province CHC/THC population covered by which reimbursement schemes by province CHC/THC catchment population’s GDP income status by province CHC/THC hospital physicians and their hospital beds ratio by province CHC/THC expenditures by province as % of total market spend CHC/THC outpatient numbers & visits and average outpatient expenditure by province

4. CHC Market Analysis and Territory Management Strategy

Concentration of CHC market segments Concentration of THC market segments Territory management of CHC and THC markets


China CHC Market Opportunities - Physicians & Patients Perspectives Contents of Report (1/2)

1. Patients & Diseases

What diseases are treated for in-patients and out-patients

Key drivers to consult in CHCs rather than big hospitals(e.g. diagnosis, retention of prescriptions, recheck of lab tests, etc.)

Current level of doctor and patient satisfaction with CHC services and gap analysis

Current trends for future services for the CHC market and CHC stations 2. CHCs and CHC Stations

Analysis of current specialties and those in future to be developed in CHCs

Analysis of typical current CHC resourcing setup: equipments, lab exams, staff, dispensary traffic and how current resourcing will look in the future

Number of medicines in the CHC dispensaries (both Western and TCMs)

Current pattern of CHC hospital purchasing: direct use of an exclusive or several distributors

Analysis of the prescriptions of medicines not on the current CHC hospitals’ formulary

3. Physicians

Number of CHC hospitals’ physicians segmented by their specialties

CHC staff profile: age, working years, education background, gender and family status.


China CHC Market Opportunities - Physicians & Patients PerspectivesContents of Report (2/2)

Typical CHC physicians’ prescription attitudes and behaviors towards patients

Various formats used for CME (continuous medical education)

Key issues and current unmet needs of CHC physicians

CHC physicians’ awareness and perceptions of local brands and MNCs’ brands

4.E-marketing Opportunity of CHC Physicians

CHC physician’s internet surfing habits

a) Frequency, location

b) Main purposes of internet surfing

c) Regularly visited websites to get medical information

CHC Physician’s Preference for Online Medical Information

a) Online CME (continuous medical education)

b) Net conference organized by pharma companies

E-marketing Opportunity for CHC Physician

a) Experience of attending e-marketing activities

b) Willingness to attend e-marketing activities

c) Favorite e-marketing activities (net conference, email, e-detailing, etc)

d) Evaluation and attitude towards e-marketing activities


China THC Market Opportunities, from Physicians and Patients Perspectives Contents of Report (1/2)

1.Patients & Diseases

What diseases are treated for in-patients and out-patients

Key drivers to consult in THCs rather than big hospitals: (e.g. diagnosis, retention of prescriptions, recheck of lab tests, etc.)

Current level of doctor and patient satisfaction with THC services and gap analysis

Current trends for future services for the THC market 2.Basic Facts of THCs

Analysis of current specialties and those in future to be developed in THCs

Analysis of typical current THC resourcing setup: equipments, lab exams, staff, dispensary traffic and how current resourcing will look in the future

Number of medicines (Western and TCMs) in the THC dispensaries

Current pattern of THC hospital purchasing: direct use of an exclusive or several distributors

Analysis of the prescriptions of medicines not on the current THC hospitals’ formulary 3.Physicians

Number of THC hospitals’ physicians segmented by their specialties

THC staff profile: age, working years, education background, gender and family status.


China THC Market Opportunities, from Physicians and Patients Perspectives Contents of Report (2/2)

Typical THC physicians’ prescription attitudes and behaviors towards patients

Various formats used for CME (Continuous Medical Education)

Key issues and current unmet needs of THC physicians

THC physicians’ awareness and perceptions of local brands and MNCs’ brands

4.E-marketing Opportunity of THC Physicians

THC physician’s internet surfing habits

a) Frequency, location

b) Main purposes of internet surfing

c) Regularly visited websites to get medical information

THC Physician’s Preference for Online Medical Information

a) Online CME (continuous medical education)

b) Net conference organized by pharma companies

E-marketing Opportunity for THC Physician

a) Experience of attending e-marketing activities

b) Willingness to attend e-marketing activities

c) Favorite e-marketing activities (net conference, email, e-detailing, etc)

d) Evaluation and attitude towards e-marketing activities


Contents


Sampling Plan


Contents of Report

Cost of Reports


Cost of Reports

Report Wave 2010 Wave 2013

1. China CHC & THC Market Overview ReportSupply & Demand

100,000 CNY16,500 USD

100,000 CNY16,500 USD

2. China CHC Market Opportunities ReportPhysicians & Patients

300,000 CNY45,000 USD

200,000 CNY33,000 USD

3. China THC Market Opportunities ReportPhysicians & Patients

NA 200,000 CNY33,000 USD

E-marketing opportunities with CHC Physicians 70,000 Cost included in Report 2

Early bird 10% discount for subscribing :

- to Report 1 before July 15

- to Reports 2 & 3 before August 15

Clients who had subscribed to version 2010 will be offered with special discountsPlease contact your account service managers.


For more information, please contact your Senior Account Service Manager:

Bruno Vayssié

Tel. : +86 21 6290 2121 x 171

Mobile : +86 134 728 725 67

E-mail : [email protected]

Thank You!

intro china chc & thc market reports 2013

Documents

chc physicians

chc patients

interviews of physicians

patients interviews

thc satisfaction of

chc thc market facts

provinces chc

interviews idis